COLISEUM CAPITAL MANAGEMENT, LLC purchased 13.3% of their position (1.54M shares) of ACCENDRA HEALTH INC/VA/ on the open market
Open‑market purchase worth $8.10M — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/14/2025ACC: 0000950170-25-109150
10% Owner
Since Feb 2025
+1.54M
Net shares
Net buyer
$8.10M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1.54M acquired
Non-Derivative Transactions3
Common Stock, par value $2 per share ("Common Stock")
Indirect
Shares
+720K
Price / share
$5.15
Trade value
$3.71M
% of position
6.2%
8/12/2025
11.56M→12.28M
Common Stock
Indirect
Shares
+325K
Price / share
$5.46
Trade value
$1.77M
% of position
2.6%
8/13/2025
12.28M→12.61M
Common Stock
Indirect
Shares
+492.85K
Price / share
$5.31
Trade value
$2.62M
% of position
3.9%
8/14/2025
12.61M→13.10M
Total
Net shares
+1.54M
Net value
$8.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $2 per share ("Common Stock") Indirect | 8/12/2025 | P · Purchase | +720K | $5.15 | $3.71M | 6.2% | 11.56M | 12.28M |
| Common Stock Indirect | 8/13/2025 | P · Purchase | +325K | $5.46 | $1.77M | 2.6% | 12.28M | 12.61M |
| Common Stock Indirect | 8/14/2025 | P · Purchase | +492.85K | $5.31 | $2.62M | 3.9% | 12.61M | 13.10M |
| Total | +1.54M | $8.10M | ||||||
Derivative Transactions0
No derivative transactions reported